TocILizumab in aorTitis in GCA (TILT) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TocILizumab in aorTitis in GCA (TILT) — Stella

Recruiting

Back to Aortitis trials

Trial locations(1 site)

France

Département de Medecine interne et d'immunologie clinique - hôpital La Pitié Salpetrière, Paris

Key details

Sponsor

Groupe français d'étude des Maladies Inflammatoires de loeil

Enrollment target

~80 participants

Started

March 2024

Primary completion

September 2026

Age range

18 Years and older

Last updated December 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov